ScoreWhy is Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. ?
1
Positive results in Mar 25
- RAW MATERIAL COST(Y) Fallen by -4.57% (YoY)
- CASH AND EQV(HY) Highest at CNY 2,601.1 MM
- DEBTORS TURNOVER RATIO(HY) Highest at 3.93%
2
With ROE of 13.33%, it has a expensive valuation with a 5.21 Price to Book Value
- Over the past year, while the stock has generated a return of 31.22%, its profits have risen by 11.2% ; the PEG ratio of the company is 3.5
- At the current price, the company has a high dividend yield of 0.9
3
Market Beating Performance
- The stock has generated a return of 31.22% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.18%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
35.21%
1.01
40.19%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.35%
EBIT Growth (5y)
3.92%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.53
Sales to Capital Employed (avg)
0.39
Tax Ratio
16.34%
Dividend Payout Ratio
36.24%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.77%
ROE (avg)
15.88%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
39
Industry P/E
Price to Book Value
5.21
EV to EBIT
32.84
EV to EBITDA
28.42
EV to Capital Employed
10.31
EV to Sales
11.85
PEG Ratio
3.50
Dividend Yield
0.90%
ROCE (Latest)
31.40%
ROE (Latest)
13.33%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -4.57% (YoY
CASH AND EQV(HY)
Highest at CNY 2,601.1 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 3.93%
-6What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 308.38 MM
ROCE(HY)
Lowest at 13.41%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.37%
Here's what is working for Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Cash and Eqv
Highest at CNY 2,601.1 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio
Highest at 3.93%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -4.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Operating Cash Flow
Lowest at CNY 308.38 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Inventory Turnover Ratio
Lowest at 1.37%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
